Correction: Evidence of brain target engagement in Parkinson's disease and multiple sclerosis by the investigational nanomedicine, CNM- Au8, in the REPAIR phase 2 clinical trials.
J Nanobiotechnology
; 22(1): 16, 2024 Jan 03.
Article
in En
| MEDLINE
| ID: mdl-38167088
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Nanobiotechnology
Year:
2024
Document type:
Article